TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23757126

Group type: EXPERIMENTAL
Intervention: Exercise Group (EG) - 10-week high-intermediate intensity aerobic exercise program (75-85% HRR)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control Group (CG) - no intervention
Number of subjects: 62
Study: 21501811

Group type: EXPERIMENTAL
Intervention: HIV education intervention designed in the United States and adapted for Swaziland
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 135
Study: 18685605

Group type: EXPERIMENTAL
Intervention: Sour tea (Hibiscus sabdariffa)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Black tea infusion
Number of subjects: 60
Study: 16706758

Group type: EXPERIMENTAL
Intervention: Frozen fat
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fresh fat
Number of subjects: 10
Study: 16500347

Group type: EXPERIMENTAL
Intervention: Vitrification with DMSO using rapid cooling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitrification with DMSO using slow cooling (long exposure)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitrification with DMSO using slow cooling (short exposure)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vitrification without DMSO using slow cooling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitrification with long-term contact of oocytes with DMSO
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitrification with short-term contact of oocytes with DMSO at room temperature
Number of subjects: 0
Study: 10787075

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (low dose intravenous epirubicin 20 mg/m2 and mitomycin 5 mg monthly for seven courses starting 5 to 6 weeks after surgery)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no adjuvant treatment)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 49
Study: 8857631

Group type: EXPERIMENTAL
Intervention: Ketamine infusion (i.v.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study: 1513962

Group type: EXPERIMENTAL
Intervention: Modified PNF techniques (PCP, 3-PIECP, 3-PIFCP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Passive stretch technique (P)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Cold application
Number of subjects: 120
Study: 6827877

Group type: EXPERIMENTAL
Intervention: Experimental group using a test order form that included actual test prices
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group using a test order form without actual prices
Number of subjects: 59
Study: 30299473

Group type: EXPERIMENTAL
Intervention: Statin therapy (simvastatin)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (untreated high blood cholesterol)
Number of subjects: 64
Study: 29730268

Group type: EXPERIMENTAL
Intervention: Bilateral thoracic paravertebral block at T8 with an infusion of 0.2% ropivacaine
Number of subjects: 53

Group type: COMPARATOR
Intervention: Thoracic epidural analgesia at T7/8 with an infusion of 0.125% bupivacaine with hydromorphone 6 μg/mL
Number of subjects: 53
Study: 26583966

Group type: EXPERIMENTAL
Intervention: Low volume training (2 sets of 5 repetitions, twice a week)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Moderate volume training (4 sets of 5 repetitions, twice a week)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 47
Study: 24822261

Group type: EXPERIMENTAL
Intervention: Computer-supported interprofessional education (IPE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pretest-posttest composite attitude toward teamwork scores
Number of subjects: 0
Study: 22438360

Group type: EXPERIMENTAL
Intervention: Single-session RF ablation (group 1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Two-session RF ablation (group 2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison between group 1 and group 2
Number of subjects: 30
Study: 20657772

Group type: EXPERIMENTAL
Intervention: Emotionally positive opponents
Number of subjects: 0

Group type: COMPARATOR
Intervention: Threatening face information
Number of subjects: 0
Study: 18366642

Group type: EXPERIMENTAL
Intervention: Obesity (BMI > or = 30 kg/m2)
Number of subjects: 6188

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 6188

Group type: EXPERIMENTAL
Intervention: Hypertension (BP > or = 140/90 mmHg and/or treatment)
Number of subjects: 6188

Group type: EXPERIMENTAL
Intervention: Dyslipidemia (high LDL-cholesterol and/or low HDL-cholesterol and/or high triglyceride levels)
Number of subjects: 6188

Group type: EXPERIMENTAL
Intervention: Diabetes (fasting plasma glucose > or = 7 mmol/l and/or treatment)
Number of subjects: 6188
Study: 15981865

Group type: EXPERIMENTAL
Intervention: Electronic nose intervention for detecting changes in body odor due to renal dysfunction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 0
Study: 12677354

Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (acute tryptophan depletion via an amino acid drink lacking tryptophan)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control mixture (balanced mixture of amino acids)
Number of subjects: 0
Study: 10573236

Group type: EXPERIMENTAL
Intervention: Sensitization to cat
Number of subjects: 11215

Group type: EXPERIMENTAL
Intervention: Sensitization to house dust mite
Number of subjects: 11215

Group type: EXPERIMENTAL
Intervention: Sensitization to timothy grass
Number of subjects: 11215

Group type: EXPERIMENTAL
Intervention: Sensitization to Cladosporium
Number of subjects: 11215
Study: 9592303

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg twice daily, clarithromycin 500 mg twice daily, amoxicillin 1,000 mg twice daily for 1 week
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg twice daily, clarithromycin 500 mg twice daily, amoxicillin 1,000 mg twice daily for 2 weeks
Number of subjects: 141

Group type: COMPARATOR
Intervention: Colloidal bismuth subcitrate 240 mg twice daily, amoxicillin 1,000 mg twice daily, metronidazole 400 mg twice daily for 2 weeks
Number of subjects: 141
Study: 1872348

Group type: EXPERIMENTAL
Intervention: Multiple choice response format (oral and written)
Number of subjects: 1078

Group type: COMPARATOR
Intervention: Usual history question (oral and written)
Number of subjects: 1078

Group type: EXPERIMENTAL
Intervention: Biochemical tests of urine samples from reported nonsmokers
Number of subjects: 1078

Group type: EXPERIMENTAL
Intervention: Nonsmokers in experimental groups
Number of subjects: 1078
Study: 31771375

Group type: EXPERIMENTAL
Intervention: High perceived family support
Number of subjects: 371

Group type: COMPARATOR
Intervention: Low perceived family support
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Controller medication use (≥8 days over 2 weeks)
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Asthma control
Number of subjects: 371
Study: 31487819

Group type: EXPERIMENTAL
Intervention: Native whey (20 g, 2 servings daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Milk protein (20 g, 2 servings daily)
Number of subjects: 30
Study: 28679741

Group type: EXPERIMENTAL
Intervention: Platelet transfusions
Number of subjects: 1077

Group type: EXPERIMENTAL
Intervention: Transfusion of platelets or RBCs
Number of subjects: 1077
Study: 26222447

Group type: EXPERIMENTAL
Intervention: OROS-methylphenidate
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: atomoxetine
Number of subjects: 160
Study: 24191395

Group type: EXPERIMENTAL
Intervention: Early invasive strategy (coronary arteriography and percutaneous coronary intervention within 24 hours after admission)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Selective invasive strategy (medically stabilized, coronary arteriography only if angina recurrence or evidence of inducible myocardial ischemia)
Number of subjects: 178
Study: 20674309

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 27
Study: 19204019

Group type: EXPERIMENTAL
Intervention: Steady/non‐steady concurrency
Number of subjects: 973

Group type: EXPERIMENTAL
Intervention: Consistent condom use with non‐steady partners
Number of subjects: 973
Study: 17718369

Group type: EXPERIMENTAL
Intervention: Harmonic tone complexes with fundamental frequencies of 110 Hz and 185 Hz, tested before and after selective adaptation.
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Unresolved adaptor stimuli presented with a diotic noise background.
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Partially resolved adaptor stimuli presented with a diotic noise background.
Number of subjects: 19
Study: 15172104

Group type: EXPERIMENTAL
Intervention: Alzheimer's disease patients (AD)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Right hippocampal T(2) in AD patients
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Amygdaloid T(2) in AD patients
Number of subjects: 51

Group type: COMPARATOR
Intervention: Vascular dementia subjects (VaD)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Healthy elderly controls
Number of subjects: 51
Study: 11601666

Group type: EXPERIMENTAL
Intervention: Comprehensive asthma education and monitoring program
Number of subjects: 22

Group type: COMPARATOR
Intervention: Routine dispensing services
Number of subjects: 22
Study: 9884175

Group type: EXPERIMENTAL
Intervention: Individualized homeopathy
Number of subjects: 1778

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1778
Study: 8118992

Group type: EXPERIMENTAL
Intervention: Plasma spray cementless THR (Mallory‐Head)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sintered bead cementless THR (PCA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cemented THR
Number of subjects: 0
Study: 2563606

Group type: EXPERIMENTAL
Intervention: Acitretin (40 mg daily for 4 weeks, then individually adjusted for 8 weeks)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Etretinate (40 mg daily for 4 weeks, then individually adjusted for 8 weeks)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Acitretin
Number of subjects: 168

Group type: COMPARATOR
Intervention: Etretinate
Number of subjects: 168
Study: 1100535

Group type: EXPERIMENTAL
Intervention: Demetrin 3 x 10 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Demetrin 3 x 20 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 31767043

Group type: EXPERIMENTAL
Intervention: Standard of care with shunt strategy
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Avoiding deep hypothermic circulatory arrest
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Centres with fewer patients with prolonged pleural effusion (<6%) and fewer complications (<41%)
Number of subjects: 320
Study: 28606176

Group type: EXPERIMENTAL
Intervention: Rituximab-containing reduced-intensity conditioning (R-RIC)
Number of subjects: 1401

Group type: COMPARATOR
Intervention: Non-rituximab-containing reduced-intensity conditioning (nonR-RIC)
Number of subjects: 1401
Study: 26702086

Group type: EXPERIMENTAL
Intervention: Statewide public and health professional awareness campaign to increase regular aspirin use
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis
Number of subjects: 0
Study: 24084510

Group type: EXPERIMENTAL
Intervention: Violent video game playing
Number of subjects: 48

Group type: COMPARATOR
Intervention: Non-violent video game playing
Number of subjects: 48

Group type: COMPARATOR
Intervention: Watching TV
Number of subjects: 48
Study: 21521834

Group type: EXPERIMENTAL
Intervention: Pantoprazole (80 mg daily) administered concomitantly (CONC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pantoprazole (80 mg daily) administered staggered by 8 to 12 hours (STAG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Clopidogrel-only regimen
Number of subjects: 20
Study: 18996507

Group type: EXPERIMENTAL
Intervention: Ketamine hydrochloride (0.5 mg/kg)
Number of subjects: 26
Study: 17060379

Group type: EXPERIMENTAL
Intervention: Monophasic waveform shocks
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Biphasic waveform shocks
Number of subjects: 168
Study: 12935797

Group type: EXPERIMENTAL
Intervention: 300 mg tolperisone hydrochloride
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 8 mg pridinol mesilate
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 11122503

Group type: EXPERIMENTAL
Intervention: Dry visco-elastic polymer pad
Number of subjects: 446

Group type: COMPARATOR
Intervention: Standard foam mattress
Number of subjects: 446
Study: 8603261

Group type: EXPERIMENTAL
Intervention: Thalidomide treatment (n=16)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Thalidomide treatment in patients with HIV‐1 and tuberculosis infections
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo treatment (n=16)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Thalidomide treatment in patients with HIV‐1 infection only
Number of subjects: 39
Study: 1584941

Group type: EXPERIMENTAL
Intervention: Amebicidal therapy coupled with image-guided percutaneous therapeutic aspiration
Number of subjects: 41

Group type: COMPARATOR
Intervention: Amebicidal therapy alone
Number of subjects: 41
Study: 2858420

Group type: EXPERIMENTAL
Intervention: Doxepin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Mequitazine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Doxepin vs Mequitazine
Number of subjects: 24
Study: 31876012

Group type: EXPERIMENTAL
Intervention: Meaning-centered group psychotherapy for cancer survivors (MCGP-CS)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Supportive group psychotherapy (SGP)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 170
Study: 28967323

Group type: EXPERIMENTAL
Intervention: Standard crisis response plan (S-CRP), N=32
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Enhanced crisis response plan (E-CRP), N=33
Number of subjects: 97

Group type: COMPARATOR
Intervention: Contract for safety, N=32
Number of subjects: 97
Study: 27506585

Group type: COMPARATOR
Intervention: Acetaminophen (500 mg/8 h) over 6 weeks
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Intra-articular leukocyte-poor PRP (LP-PRP) injections (three injections, once every 2 weeks)
Number of subjects: 65
Study: 24819349

Group type: EXPERIMENTAL
Intervention: Kinesio Taping® (KT)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 94
Study: 22310408

Group type: EXPERIMENTAL
Intervention: Computed tomography (CT) scans
Number of subjects: 24

Group type: COMPARATOR
Intervention: Plain radiographs
Number of subjects: 24
Study: 20620261

Group type: EXPERIMENTAL
Intervention: Diagnostic announcement protocol (P)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Self-Appraisal of Illness Questionnaire (SAIQ)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Positive and Negative Syndrome Scale (PANSS)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (SP)
Number of subjects: 31
Study: 18591575

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (d-amph) 10 mg single dose
Number of subjects: 20
Study: 24453535

Group type: EXPERIMENTAL
Intervention: Strength Training (ST)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Endurance Training (ET)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sedentary Control (C)
Number of subjects: 36
Study: 12060506

Group type: EXPERIMENTAL
Intervention: 400 mg single dose of itraconazole
Number of subjects: 50

Group type: COMPARATOR
Intervention: 7-day 200 mg daily dose of itraconazole
Number of subjects: 50
Study: 10221945

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Mianserin
Number of subjects: 372

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Counselling and emotional support (combined with active drug)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Counselling and emotional support (simple psychological treatment)
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Gender response
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Recurrent depression
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: First episode of depression
Number of subjects: 372
Study: 7884414

Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy (4 cycles of chemotherapy for 3 months before surgery followed by 4 cycles after surgery)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Adjuvant therapy (8 cycles of chemotherapy over 6 months after surgery)
Number of subjects: 212
Study: 2144492

Group type: EXPERIMENTAL
Intervention: Collagen-treated graft
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ordinary Dacron graft
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 375459

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus anticoagulants
Number of subjects: 24

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 24
Study: 31269917

Group type: EXPERIMENTAL
Intervention: Peer support for 12 months
Number of subjects: 226

Group type: COMPARATOR
Intervention: No peer support (control)
Number of subjects: 226
Study: 29957101

Group type: EXPERIMENTAL
Intervention: Estradiol Valerate/Dienogest (EV/DNG)
Number of subjects: 341

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 341
Study: 27373329

Group type: EXPERIMENTAL
Intervention: Bet v 1 COPs 50 μg
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Bet v 1 COPs 100 μg
Number of subjects: 239

Group type: COMPARATOR
Intervention: Placebo (saline and aluminum hydroxide)
Number of subjects: 239
Study: 25237124

Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 21971535

Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy (12 sessions, 1 h/week) in psychology private practices
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy in a small county hospital
Number of subjects: 138

Group type: COMPARATOR
Intervention: Supportive therapy
Number of subjects: 138

Group type: COMPARATOR
Intervention: Waiting list controls
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy (study 1)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy (study 2)
Number of subjects: 138
Study: 21156074

Group type: EXPERIMENTAL
Intervention: Computer-assisted preoperative planning and peri-operative patient-specific surgical guides
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional preoperative planning
Number of subjects: 0
Study: 17653314

Group type: EXPERIMENTAL
Intervention: Singulair 4 mg once daily for 12 weeks
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Budesonide aerosol 200 ug once or twice daily for 12 weeks
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (healthy infants)
Number of subjects: 37
Study: 15584062

Group type: EXPERIMENTAL
Intervention: Short-term radiotherapy followed by TME
Number of subjects: 924

Group type: COMPARATOR
Intervention: TME alone
Number of subjects: 924
Study: 12090310

Group type: EXPERIMENTAL
Intervention: Family preservation program (FP Program)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5-day residential program (5DR Program)
Number of subjects: 0
Study: 10069193

Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg, once daily for 8 weeks)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 8528112

Group type: EXPERIMENTAL
Intervention: Conducting liquid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-conducting liquid
Number of subjects: 0
Study: 1663226

Group type: EXPERIMENTAL
Intervention: Morphine (0.3 mg/kg bodyweight)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 20
Study: 7128670

Group type: EXPERIMENTAL
Intervention: Terbutaline 0.125 mg and 0.250 mg via pressurized aerosol with pear-shaped spacer
Number of subjects: 13

Group type: COMPARATOR
Intervention: Terbutaline 1.25 mg and 2.50 mg via nebulized solution
Number of subjects: 13

Group type: COMPARATOR
Intervention: Initial placebo treatment for both groups
Number of subjects: 13
Study: 31274152

Group type: EXPERIMENTAL
Intervention: Electrically guided LV lead placement with post-implant VVd optimization
Number of subjects: 122

Group type: COMPARATOR
Intervention: Imaging-guided LV lead implantation (control group)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Electrically guided CRT implantation
Number of subjects: 122
Study: 29049868

Group type: EXPERIMENTAL
Intervention: Intense intervention group (home-based assessments at 6-month intervals and a 12-month multidisciplinary program with weekly group sessions)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Minimal-intensity control group (home-based assessments and advice at each 6-month follow-up)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Intense intervention group (with ≥70% attendance)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 203
Study: 25627090

Group type: EXPERIMENTAL
Intervention: CFH +/+ HTRA1 -/-
Number of subjects: 2982

Group type: EXPERIMENTAL
Intervention: CFH -/- HTRA1 +/+
Number of subjects: 2982

Group type: EXPERIMENTAL
Intervention: CFH +/+ HTRA1 +/+
Number of subjects: 2982
Study: 24397584

Group type: EXPERIMENTAL
Intervention: saxagliptin + metformin
Number of subjects: 858

Group type: COMPARATOR
Intervention: glipizide + metformin
Number of subjects: 858
Study: 22809843

Group type: EXPERIMENTAL
Intervention: Aspirin resistance defined by response to arachidonic acid after 3, 5 and 7 minutes (approximately 30% of patients)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Aspirin resistance defined by response to adenosine diphosphate after 3 minutes (approximately 17% of patients)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Aspirin resistance (49 patients)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Platelet CD62P expression at rest
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Platelet CD62P expression stimulated by arachidonic acid
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Platelet CD62P expression stimulated by adenosine diphosphate
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Aspirin resistance in patients with greatest renal disease
Number of subjects: 169
Study: 20186975

Group type: EXPERIMENTAL
Intervention: Escitalopram 20 mg/day + Depression Care Management (DCM) + Interpersonal Psychotherapy (IPT) for 16 weekly sessions
Number of subjects: 124

Group type: COMPARATOR
Intervention: Escitalopram 20 mg/day + Depression Care Management (DCM) without IPT
Number of subjects: 124